Authors Posts by BiotechBlog

BiotechBlog

3290 POSTS 0 COMMENTS

Affymetrix sells new gene chip / Chip represents full human genome
Affymetrix Inc. of Santa Clara won the race Thursday to market a single gene chip packed with fragments from each of the 35,000 known genes that make up the human genome.
But two other Bay area companies, Agilent Technologies of Palo Alto and Applied Biosystems of Foster City, are close behind with their own versions of a whole-genome microarray, or chip.
The chips mark a major technical advance in the use of human genetic information to find new drugs, and eventually, to tailor treatments based on differences in each patient’s DNA.

FDA’s McClellan Calls for More Sharing of Drug R&D Costs
The U.S. is bearing a disproportionate share of drug research and development costs for medicines used globally, FDA commissioner Mark McClellan said Thursday.

He called for more equitable cost sharing and price setting. ‘If we do not find better ways to share the burden of developing new drugs and biologics, all of us will suffer’

BIOTECH THAWS OUT:
“Small drug discovery firms are capitalizing on the positive momentum that’s returned to the market for biotechnology stocks. A dozen have announced plans this quarter to launch initial public stock offerings (IPOs), while nearly as many more hope to raise money through follow-on bids. The upturn, if it persists, may help rescue a sector where limited cash flow has precipitated major cutbacks and consolidation.”